EGFR and neoplasm: Additionally, KAT5 was recently implicated is promoting GBM tumor growth by upregulating cholesterol synthesis (via acetylation of HMGCS1)94, lipolysis of lipid droplets (via acetylation of choline kinase)95, and EGFR-PI3K activity (via PFKP acetylation)96.